Research Article
Zika Virus Alters the Viscosity and Cytokines Profile in Human Colostrum
Table 1
Maternal and neonate parameters according to maternal gestational ZIKV infection.
| | Maternal and child parameters | Control () | ZIKV () |
| | Age (years) | | | | Signs and symptoms of gestational Zika | 00 (0.00%) | 20 (100.00%) | | RT-PCR (serum) (%)—ZIKV+ | — | 20 (100.00%) | | Gestational age at ZIKV infection (trimester) | | | | 1 trimester | — | 13 (65.00%) | | 2 trimester | — | 6 (30.00%) | | 3 trimester | — | 1 (5.00%) | | Gestational age at delivery (weeks) | 38.95 (±1.00) | 39.65 (±0.99) | | Infant sex | | | | Female (%) | 11 (55.00%) | 11 (55.00%) | | Male (%) | 9 (45.00%) | 9 (45.00%) | | Birth weight (g) | 3375.50(±444.89) | 3356.50 (±407.43) | | Birth height (cm) | 45.50 (±3.46) | 48.00 (±3.52) | | Brain perimeter (cm) | 34.20(±0.89) | 33.76 (±0.66) | | Microcephaly | 00 (0.00%) | 00 (0.00%) | | Infant health complications (outcomes at 1 year postpartum) | — | | | Hearing impairment | — | 2 (10.00%) | | Vision impairment | — | 1 (5.00%) | | Convulsion | — | 1 (5.00%) | | Neuropsychomotor development delay | — | 2 (10.00%) | | ZIKA IgG/IgM (colostrum)—negative (%) | 20 (100.00%) | — | | PCR (colostrum)—ZIKV and flavivirus—(%) | — | 20 (100.00%) |
|
|
Maternal and neonatal data are shown as mean (±SD) or amostral number (%).
|
